Department of Neurosurgery, IRCCS Policlinico S Matteo, University of Pavia, 27100 Pavia, Italy.
Acta Neurochir (Wien). 2009 Nov;151(11):1431-7. doi: 10.1007/s00701-009-0428-9. Epub 2009 Jun 24.
We reviewed the clinical outcomes resulting from various closure techniques used following endoscopic endonasal surgery for lesions in the sellar and parasellar regions. We compared our current closure technique, which uses a biological matrix of native equine collagen (TissuDura) fixed with fibrin sealant (Tisseel), with the technique we employed previously, using autologous materials, in order to assess the comparative efficacy and tolerability of both methods over the medium- to long-term.
A review was conducted of all cases of endonasal endoscopic intervention carried out in our institution between 1997 and 2007. Operations performed between January 1st 1997 and December 31st 2003 involved a sellar closure technique using autologous materials, either alone or supported by fibrin sealant. From January 1st 2004, sellar reconstruction techniques involving resorbable heterologous materials were used in the closure phases. Post-operatively, clinico-endoscopic assessments took place at 15 days, 1, 3, and 6 months and yearly thereafter, supplemented by magnetic resonance imaging (MRI) scanning at 3 months and annually.
Between January 1st 1997 and December 31st 2003, 79 operations were performed in which the sellar closure technique involved the use of autologous materials. Between January 1st 2004 and January 1st 2008, 125 operations were performed in which biomaterials were used for sellar closure. The incidence of complications (fluid fistula) was 2.5% in the autologous materials closure group and 1.6% in the biomaterials closure group. The most marked difference between the two approaches was seen at 1-month follow-up, when restoration of mucociliary transport in the sphenoidal sinus and physiological functionality of the nasal mucosa and paranasal sinuses were observed to be superior in the biomaterials patient cohort.
The development of biomaterials for closure of the sellar floor offers a viable alternative to traditional techniques using autologous materials.
我们回顾了经鼻内镜手术治疗鞍区和鞍旁病变后,采用不同闭合技术的临床结果。我们比较了目前使用生物基质天然马胶原(TissuDura)固定纤维蛋白胶(Tisseel)的闭合技术,以及之前使用自体材料的技术,以评估这两种方法在中-长期的相对疗效和耐受性。
对 1997 年至 2007 年期间在我们机构进行的所有经鼻内镜介入手术病例进行了回顾。1997 年 1 月 1 日至 2003 年 12 月 31 日期间进行的手术采用自体材料单独或结合纤维蛋白胶进行鞍底闭合。自 2004 年 1 月 1 日起,在闭合阶段使用可吸收异种材料进行鞍底重建技术。术后 15 天、1 个月、3 个月和 6 个月以及此后每年进行临床内镜评估,并在术后 3 个月和每年进行磁共振成像(MRI)扫描。
1997 年 1 月 1 日至 2003 年 12 月 31 日期间,79 例手术采用自体材料进行鞍底闭合技术。自 2004 年 1 月 1 日至 2008 年 1 月 1 日期间,125 例手术采用生物材料进行鞍底闭合。自体材料闭合组并发症(液漏)发生率为 2.5%,生物材料闭合组为 1.6%。两种方法之间最明显的差异出现在 1 个月随访时,生物材料组蝶窦黏膜纤毛传输和鼻黏膜及副鼻窦生理功能恢复更好。
生物材料在鞍底闭合中的应用为传统自体材料技术提供了一种可行的替代方法。